ARSA protein and gene therapy has been shown to be a safe therapeutic approach for metachromatic leukodystrophy in humans55–57, and future studies are warranted to assess the potential for ARSA as a therapeutic strategy for the treatment of type 2 diabetes. The gene discussed is ARSA; the disease is metachromatic leukodystrophy.